跳至主要内容
临床试验/JPRN-UMIN000041430
JPRN-UMIN000041430招募中未知

Benefit and Harm of Angiotensin Converting Enzyme Inhibitor and Angiotensin Receptor Blocker in COVID-19 Patients: A Review Protocol of Systematic Review and Meta-Analysis - Benefit and Harm of Angiotensin Converting Enzyme Inhibitor and Angiotensin Receptor Blocker in COVID-19 Patients: A Review Protocol of Systematic Review and Meta-Analysis

Faculty of Medicine, Universitas Airlangga0 个研究点开始时间: 2020年8月16日最近更新:
适应症

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Others,meta-analysis etc

入排标准

年龄范围
18years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • The exclusion criteria are (1) non-English articles; (2) review, case-control studies, case reports, and case series; (3) studies without full-text articles; (4) studies that do not contain primary data in their published articles; and (5) unpublished records such as conference papers, theses, and patents.

研究者

相似试验